Skip to content

Utility Navigation

  • Important Safety Information
  • Prescribing Information
  • Healthcare Professionals Site

Main Navigation

  • Cisplatin-induced Hearing Loss
  • What is PEDMARK?
    • How is PEDMARK given?
    • How does PEDMARK work?
  • Study Results
  • Safety
  • Fennec HEARS™
  • Helpful Tools

PEDMARK Patient Brochure

Posted on November 30, 2022 (November 30, 2022) by gmh-dev

Important product information written for patients/families to help explain the role of PEDMARK and what to expect.

Post navigation

 PEDMARK Dosing Guide

For US Patients and Caregivers Only

PEDMARK® and Fennec® are registered trademarks of Fennec Pharmaceuticals Inc.
Fennec HEARS™ is a trademark of Fennec Pharmaceuticals Inc.
©2023 Fennec Pharmaceuticals Inc. All rights reserved.
FEN-1447-v1 12/22

  • Contact Us
  • Privacy Policy
  • Terms & Conditions
  • Careers
  • Sitemap

The PEDMARK website is for US healthcare professionals only. Click "continue" only if you are a US healthcare professional.

You are now leaving PEDMARK.com.

Would you like to leave this site?